HumingAI · AI PHARMA CONSULTING · FDE
Make patient diversity a clear coordinate for development.
Connect exploratory signals with response, safety and indication choices through an evidence-led biomarker strategy.
Key topics
- Mechanism mapping：Connect phenotype, pathway, genetics and tissue context in one research map.
- Evidence ranking：Turn public science and internal observations into transparent priorities.
- Validation design：Define the next experiment that can truly change the decision.
What you receive
- Mechanism and opportunity landscape
- Evidence-weighted priority matrix
- Validation-ready experiment brief